WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Transfusion

• Publication date

  2003-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1537-2995.2003.00443.xPMID 12823755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Th1 and Th2 cells.

  2001cited by this paper
• Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion.

  2001cited by this paper
• Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?

  2001cited by this paper
• Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent.

  2000cited by this paper
• M-1/M-2 Macrophages and the Th1/Th2 Paradigm1

  2000cited by this paper
• T-cell subsets (Th1 versus Th2).

  2000cited by this paper
• Blood Transfusion in Clinical Medicine, 10th edition

  1999cited by this paper
• Cutting Edge: CD40 Engagement Up-Regulates Cyclooxygenase-2 Expression and Prostaglandin E2 Production in Human Lung Fibroblasts

  1998cited by this paper
• Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial.

  1998cited by this paper
• Blood transfusion and total joint replacement surgery: T helper 2 (TH2) cytokine secretion and clinical outcome

  1998cited by this paper
• Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery.

  1998cited by this paper
• Th1 and Th2 cells.

  1998cited by this paper
• CD40 engagement up-regulates cyclooxygenase-2 expression and prostaglandin E2 production in human lung fibroblasts.

  1998cited by this paper
• CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

  1998cited by this paper
• A central role of CD40 ligand in the regulation of CD4+ T-cell responses.

  1996cited by this paper
• Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery.

  1996cited by this paper
• The expanding universe of T-cell subsets: Th1, Th2 and more.

  1996cited by this paper
• The transfusion immunomodulation theory: the Th1/Th2 paradigm and an analogy with pregnancy as a unifying mechanism.

  1996cited by this paper
• Th1 and Th2 in human diseases.

  1996cited by this paper
• The effects of blood transfusion on cytokine production by TH1 and TH2 lymphocytes in the mouse.

  1996cited by this paper
• Cytokine secretion after allogeneic or autologous blood transfusion.

  1995cited by this paper
• Tolerance, danger, and the extended family.

  1994cited by this paper
• Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells.

  1993cited by this paper
• Functional dendritic cells are required for transfusion-induced sensitization in canine marrow graft recipients.

  1988cited by this paper
• Immune Response to Chronic Red Blood Cell Transfusion

  1983cited by this paper
• Blood transfusion in clinical medicine

  1973cited by this paper

• The wider perspective: Barriers and recommendations for transfusion support for patients with sickle cell disease in low‐ and middle‐income countries

  2025cites this paper
• Study of Expression of MST3 in Myeloid Leukaemia

  2025influential citation
• Molecular advances in transfusion medicine: a narrative review

  2025cites this paper
• ABO blood group, ABO mismatched transfusions and leukoreduction of transfusions in hemostatic resuscitation studies

  2024cites this paper
• An Expert Overview on Therapies in Non-Transfusion-Dependent Thalassemia: Classical to Cutting Edge in Treatment

  2023cites this paper
• Frequency of red blood cell allo-immunization in patients undergoing blood transfusion at the Uganda Cancer Institute

  2023cites this paper
• An overview of red blood cell and platelet alloimmunisation in transfusion.

  2022cites this paper
• National Blood Foundation 2021 Research and Development summit: Discovery, innovation, and challenges in advancing blood and biotherapies

  2022cites this paper
• How do we forecast tomorrow's transfusion? -next generation transfusion practices to improve recipient safety.

  2022cites this paper
• High B‐cell activating factor levels in multi‐transfused thalassemia patients

  2021cites this paper
• Rate of RhD‐alloimmunization after the transfusion of multiple RhD‐positive primary red blood cell‐containing products

  2021cites this paper
• Anti-D alloimmunization after platelet transfusion

  2021cites this paper
• A study of red blood cell alloimmunization and autoimmunization among 200 multitransfused Egyptian β thalassemia patients

  2020cites this paper
• Methods of RBC Alloimmunization to ABO and Non-ABO Antigens, and Test Methodologies

  2020cites this paper
• Alloimmunization and autoimmunization in adult transfusion-dependent thalassemia patients: a report from a comprehensive center in Israel

  2020cites this paper
• Red cell alloantibodies in beta-thalassaemia major patients’ blood referring to the regional blood transfusion center of Tehran, Iran

  2020cites this paper
• Transfusion-related red blood cell alloantibodies: induction and consequences.

  2019cites this paper
• Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience.

  2019cites this paper
• Red cell alloimmunization in transfusion-dependent and transfusion-independent beta thalassemia: A review from the Eastern Mediterranean Region (EMRO).

  2019cites this paper
• Transfusion Support of the Patient with Sickle Cell Disease Undergoing Transplantation

  2018cites this paper
• The prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen‐matched red blood cells for thalassemia transfusions: a 10‐year experience at a tertiary care hospital

  2018cites this paper
• Genomewide association study of HLA alloimmunization in previously pregnant blood donors

  2018cites this paper
• Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods

  2018cites this paper
• Risks of red blood cell alloimmunization in transfusion‐dependent β‐thalassemia in Oman: a 25‐year experience of a university tertiary care reference center and a literature review

  2018cites this paper
• Transfusion in Haemoglobinopathies: Review and recommendations for local blood banks and transfusion services in Oman.

  2018cites this paper
• Indications for red cell transfusions in pediatric patients.

  2018cites this paper
• Common Significant Non-ABO Antibodies and Blood Group Antigen Alloimmunization

  2018cites this paper
• Transfusion for Patients With Sepsis in 2018

  2018cites this paper
• Determinants of red blood cell alloantibody detection duration: analysis of multiply alloimmunized patients supports peritransfusion factors

  2017cites this paper
• How shall we transfuse Hippolyta?

  2017cites this paper
• Immunological complications of blood transfusions.

  2016cites this paper
• Selection of GP. Mur antigen‐negative RBC for blood recipients with anti‐‘Mia’ records decreases transfusion reaction rates in Taiwan

  2016cites this paper
• Transfusion‐related alloimmunization in children: epidemiology and effects of chemotherapy

  2016cites this paper
• Red Blood Cell Antibodies in Hematology/Oncology Patients: Interpretation of Immunohematologic Tests and Clinical Significance of Detected Antibodies.

  2016cites this paper
• Understanding red blood cell alloimmunization triggers.

  2016cites this paper
• Riboflavin‐ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells

  2016cites this paper
• Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt

  2016cites this paper
• Handling a transfusion haemolytic reaction

  2015cites this paper
• Frequency and specificity of red cell antibodies in thalassemia patients in Albania

  2015cites this paper
• Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility

  2015cites this paper
• Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation

  2015cites this paper
• Transforming growth factor‐β released by apoptotic white blood cells during red blood cell storage promotes transfusion‐induced alloimmunomodulation

  2015cites this paper
• Prevalence and specificities of red cell alloantibodies in transfusion-dependent beta thalassemia patients in Yazd

  2015cites this paper
• Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models

  2014cites this paper
• Red blood cell alloimmunization mitigation strategies.

  2014cites this paper
• Responder Individuality in Red Blood Cell Alloimmunization

  2014cites this paper
• Red Blood Cell Antibodies in Thalassemia Patients in Northern India: Risk Factors and Literature Review

  2014cites this paper
• Frequency and Specificity of Red Blood Cell Alloimmunization in Chilean Transfused Patients

  2014cites this paper
• Transfusion therapy and alloimmunization in Thalassemia Intermedia: a 10 year experience at a tertiary care university hospital.

  2014cites this paper
• Immunisierungsfrequenz nach Rhesus-(D)-inkompatibler Transfusion von leukozytendepletierten Erythrozytenkonzentraten

  2014cites this paper
• Post-transfusion and maternal red blood cell alloimmunization in Uganda

  2013cites this paper
• Transfusion immunomodulation from a clinical perspective: an update

  2013cites this paper
• Red blood cell alloimmunisation among Chinese patients with β-thalassaemia major in Taiwan.

  2013cites this paper
• RED CELL ALLOIMMUNIZATION IN MULTI TRANSFUSED PATIENTS WITH BETA THALASSEMIA MAJOR – A STUDY FROM SOUTH INDIA -

  2013cites this paper
• Grundlagen und Besonderheiten der Transfusionstherapie bei Hämoglobinopathien

  2013cites this paper
• Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigens.

  2013cites this paper
• Challenges of alloimmunization in patients with haemoglobinopathies

  2012cites this paper
• High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease.

  2012cites this paper
• Red Cell Alloantibodies in Multiple Transfused Thalassaemia Patients.

  2011cites this paper
• Alloimmunization and Erythrocyte Autoimmunization in Transfusion-dependent Egyptian Thalassemic Patients

  2011cites this paper
• High frequency of autoimmunization among transfusion-dependent Tunisian thalassaemia patients.

  2011cites this paper
• Reduktion der Inzidenz von antierythrozytären Alloantikörpern durch die Leukozytendepletion von Erythrozytenkonzentraten

  2011cites this paper
• Red cell alloimmunization in a diverse population of transfused patients with thalassaemia

  2011cites this paper
• Residual risk of D alloimmunization: is it time to feel safe about platelets from D+ donors?

  2011cites this paper
• Platelet transfusions from D+ donors to D− patients: a 10‐year follow‐up study of 1014 patients

  2011cites this paper
• Dermatomyositis and polymyositis: new treatment targets on the horizon.

  2011cites this paper
• Clinical effects of leucoreduction of blood transfusions.

  2011cites this paper
• Gemcitabine‐based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non‐Hodgkin's lymphoma

  2009cites this paper
• Red cell alloimmunization in multitransfused patients and multiparous women

  2009cites this paper
• HLA type and risk of alloimmunization in sickle cell disease

  2009cites this paper
• Transfusion‐related immune reactions: pathogenesis and prevention

  2009cites this paper
• Systolic blood pressure peak during maximal exercise testing: A possible determinant of endothelial turnover in healthy subjects

  2009cites this paper
• Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization?

  2009cites this paper
• Familial sideroblastic anemia associated with cardiac atrial septal defect

  2009cites this paper
• Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission

  2009cites this paper
• Lack of significant de novo HLA allosensitization in ventricular assist device recipients transfused with leukoreduced, ABO identical blood products.

  2009cites this paper
• One big unhappy family: transfusion alloimmunization, thrombosis, and immune modulation/inflammation

  2009cites this paper
• The role of inflammation in alloimmunization to antigens on transfused red blood cells

  2008cites this paper
• Antibody screening in repeatedly transfused patients.

  2008cites this paper
• The transfusion of pre storage leukoreduced packed red blood cells to injured patients.

  2008cites this paper
• Red Blood Cell Alloimmunization after Blood Transfusion

  2007cites this paper
• Chapter 52 – Transfusion-Related Immunomodulation

  2007cites this paper
• Chapter 4 – Principles of Red Blood Cell Allo- and Autoantibody Formation and Function

  2007cites this paper
• Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells

  2006cites this paper
• Alloimmunization among patients with transfusion‐dependent thalassemia in Taiwan

  2006cites this paper
• Red cell immunization in multiply transfused Malay thalassemic patients.

  2006cites this paper
• A YOUNG FEMALE BRAZILIAN WITH SICKLE CELL DISEASE WHO HAD DIFFICULTY OBTAINING COMPATIBLE BLOOD FOR TRANSFUSION DUE TO MULTIPLE ALLOANTIBODIES (UNEXPECTED ANTIBODIES) AGAINST ERYTHROCYTES

  2006cites this paper
• Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study

  2005cites this paper
• Pre‐storage leucocyte depletion and transfusion reaction rates in cancer patients

  2005cites this paper
• Immunology of Leucocytes, Platelets and Plasma Components

  2005cites this paper
• Costs associated with blood transfusions in Sweden – the societal cost of autologous, allogeneic and perioperative RBC transfusion

  2005cites this paper
• What would Karl Landsteiner do? The ABO blood group and stem cell transplantation

  2005cites this paper
• LEUCOREDUCTION UNE MESURE ENVISAGEABLE DANS LE CADRE DE LA POLITIQUE NATIONALE DE SECURITE DES

  2004cites this paper
• Collection of white blood cell‐reduced plasma by apheresis

  2004cites this paper
• Optimizing platelet transfusion therapy.

  2004cites this paper
• Open heart surgery for small children without homologous blood transfusion by using remote pump head system.

  2004cites this paper
• The effect of universal leukoreduction on postoperative infections and length of hospital stay in elective orthopedic and cardiac surgery

  2004cites this paper
• Should red cell transfusions be leukoreduced in critically ill patients?

  2004cites this paper
• Diagnosing shock via artificial intelligence: applying machine learning techniques to medicine.

  2004cites this paper
• Fibrin sealants in surgical or traumatic hemorrhage.

  2004cites this paper